Pfizer, BioNTech ask U.S. regulators to OK COVID-19 vaccine for kids

Published by

WASHINGTON (Reuters) – Pfizer Inc and BioNTech said on Thursday they had asked U.S. regulators to approve emergency use of their COVID-19 vaccine for children aged from five to 11, Pfizer said in a post on Twitter. “We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12," the company said. (Reporting by Susan Heavey, Editing by Timothy Heritage)

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *